Montfavet, France

Eric Manginot

USPTO Granted Patents = 10 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Montpellier, FR (2000)
  • Montfavet, FR (2002 - 2010)

Company Filing History:


Years Active: 2000-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Eric Manginot: Innovator in Pharmaceutical Processes

Introduction

Eric Manginot is a notable inventor based in Montfavet, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing useful intermediates. With a total of 10 patents to his name, Manginot's work has implications for cancer treatment and other medical applications.

Latest Patents

One of his latest patents focuses on processes for the production of 3-(pyridin-4-yl)-3-hydroxy-pentanoic acid derivatives. This new process is aimed at the asymmetric production of these derivatives, which are useful intermediates in the manufacture of compounds known to exhibit antiproliferative activity. Another significant patent involves analogues of camptothecin, which are compounds useful in the treatment of cancer. These compounds are formulated in pharmaceutical compositions that can potentially improve patient outcomes.

Career Highlights

Throughout his career, Eric Manginot has worked with various organizations, including Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.) and Société d'Expansion Scientifique Expansia. His work in these companies has allowed him to develop innovative solutions in the pharmaceutical industry.

Collaborations

Manginot has collaborated with notable professionals in his field, including Jean-Bernard Cazaux and Alain Rolland. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Eric Manginot's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents not only advance scientific knowledge but also hold promise for improving cancer treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…